title: Brain extraction and distribution of 99mTc-bicisate in humans and in rats.
abstract: Blood-brain barrier (BBB) passage of the flow tracer ethylenediylbis-L-cystein diethylester (bicisate, ECD) was measured repeatedly in five patients by means of the intravenous (i.v.) double-indicator technique using 24Na+ as an intravascular cotracer. After i.v. injection, the arterial concentration curve of 99mTc-bicisate was delayed and dispersed compared with that of the intravascular cotracer, presumably due to lung retention of the flow tracer. The corrected cerebral venous output curves were fitted using a three-compartment model with four parameters. At resting cerebral blood flow (CBF) values, the unidirectional brain extraction was 0.57 +/- 0.05, the permeability-surface area product for passage from blood to brain (PS1) was 0.48 +/- 0.07 ml/g/min, and the distribution volume for bicisate was 0.74 +/- 0.20 (mean +/- SD). In a single patient, BBB transport after i.v. injection of bicisate was compared with that of a similar flow tracer, d,l-hexamethylpropyleneamine oxime (HM-PAO), and similar values were found for the two tracers. In 19 rats, the brain extraction of bicisate was measured by means of the intracarotid double-indicator technique. The brain extraction was measured at resting, decreased, and increased CBF values. Low CBF values were obtained by hyperventilation and high values by hypercapnia. The degree of backflux of tracer from brain to blood was evaluated by means of the three-compartment model and was found to be negligible in these experiments. The brain extraction was 0.70 +/- 0.1 and PS1 was 0.94 +/- 0.27 ml/g/min. During hypercapnia, CBF increased from 0.77 to 1.09 ml/g/min, leading to a significant decrease in brain extraction, from 0.70 to 0.56.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Neurology, University Clinic Rigshospitalet, Copenhagen, Denmark.
authors.forename: G M
authors.initials: GM
authors.lastname: Knudsen
authors.forename: A R
authors.initials: AR
authors.lastname: Andersen
authors.forename: F E
authors.initials: FE
authors.lastname: Somnier
authors.forename: C
authors.initials: C
authors.lastname: Videbaek
authors.forename: S
authors.initials: S
authors.lastname: Hasselbalch
authors.forename: O B
authors.initials: OB
authors.lastname: Paulson
mesh_terms: D000328:Adult; D000818:Animals; D001158:Arteries; D001692:Biological Transport; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism*; D002560:Cerebrovascular Circulation; D003545:Cysteine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015609:Organotechnetium Compounds / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D010091:Oximes / Q000493:pharmacokinetics; D051381:Rats; D017208:Rats, Wistar; D012979:Sodium Radioisotopes; D014018:Tissue Distribution; D014680:Veins
chemical_list: D015609:Organotechnetium Compounds; D010091:Oximes; D012979:Sodium Radioisotopes; C068296:hexamethylpropyleneamine oxime; C059659:technetium Tc 99m bicisate; D003545:Cysteine